脑卒中幸存者骨质疏松筛查和治疗利用率调查数据表

数据集获取（Figshare）

• 源站标题：DataSheet_1_Utilization of screening and treatment for osteoporosis among stroke survivors.docx
• DOI：10.3389/fendo.2022.1043863.s001
• 发布日期：2022-12-01
• 文件数：1 个
• 文件总体积：682.22 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Utilization_of_screening_and_treatment_for_osteoporosis_among_stroke_survivors_docx/21653300

命令行下载

curl -L -o "DataSheet_1_Utilization of screening and treatment for osteoporosis among stroke survivors.docx" "https://ndownloader.figshare.com/files/38390228"

文件清单

• DataSheet_1_Utilization of screening and treatment for osteoporosis among stroke survivors.docx（682.22 KB）

文件总体积 682.22 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

BackgroundStroke survivors are prone to osteoporosis and fractures. However, bone mineral density (BMD) testing and osteoporosis treatment were underutilized in patients with recent stroke. We aimed to examine whether stroke has an impact on the utilization of BMD testing and osteoporosis treatment as well as the determinants of their utilization in stroke patients using nationwide population-based data in Taiwan.
MethodsWe identified patients aged 55 years and older who were hospitalized for hemorrhagic or ischemic stroke as the stroke cohort, and age- and sex-matched patients hospitalized for reasons other than stroke, fracture, or fall as the non-stroke cohort. We used the Fine-Gray sub-distribution hazard competing risk regression model to determine the predictors for BMD testing and osteoporosis treatment.
ResultsA total of 32997 stroke patients and 32997 age- and sex-matched controls comprised the stroke and non-stroke cohorts, respectively. BMD testing and osteoporosis treatment were performed in 1.0% and 5.2% of the stroke patients, respectively, within one year after hospitalization while these measures were performed in 0.8% and 4.7% of the controls. Stroke patients were more likely to receive BMD testing (adjusted hazard ratio [HR] 1.33; 95% confidence interval [CI] 1.11–1.58) and osteoporosis treatment (adjusted HR 1.19; 95% CI 1.11–1.29). Female sex, osteoporosis, prior BMD testing, and low-trauma fractures after stroke increased the likelihood of using BMD testing and osteoporosis treatment whereas greater stroke severity reduced the likelihood of receiving both measures.
ConclusionsBoth BMD testing and osteoporosis treatment were underutilized among stroke survivors even though they had a higher chance of receiving both measures than non-stroke patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fendo.2022.1043863.s001（source: https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Utilization_of_screening_and_treatment_for_osteoporosis_among_stroke_survivors_docx/21653300）。